Source: Spindiag GmbH
The PCR test is, so to speak, the "gold standard" for the reliable diagnosis of pathogens. Here, the genetic material of the pathogen is detected in a molecular diagnostic analysis procedure. A smear is taken from the throat, mouth or nose area, sent to the laboratory and further examined there. It usually takes 1-2 days before a result is available. Valuable time in which there is no reliable statement as to whether a patient has tested positive and must therefore be quarantined or not.
The Freiburg-based medical technology start-up Spindiag and the Hahn-Schickard Research Institute have now received 6 million euros in funding from the state of Baden-Württemberg. The money will be used to expand the test platform, which is already being developed for other pathogens, to the detection of the SARS-CoV-2 virus and make it ready for market launch. The method is currently undergoing analytical testing and is expected to be available on the market in late summer 2020. The new rapid test (see picture) is to be used directly at the point of care, i.e. at the place where the sample is taken, in order to enable diagnosis within 30 to 40 minutes. The method is user-friendly and could easily be integrated into everyday clinical practice. In theory, it would also be conceivable to use the test device in doctors' practices or retirement homes.
Spindiag was founded in 2016 as a spin-off from the renowned Hahn-Schickard-Institute for Microanalysis Systems. Over the last few years, Spindiag has developed a flexible platform for the diagnosis of infectious diseases, which in future will enable a large number of relevant tests for infectious diseases.
In order to be prepared for the market launch, BESTMINDS supports Spindiag in the recruitment of additional sales specialists. Siegfried Faix and Bernhard Joekel are experts in the field of medical technology, with a combined experience of more than 40 years in the industry and a broad and well-maintained network in the industry.
Graduate in Business Management, Managing Partner
T +49 761 888 51 23 10
F +49 761 888 51 23 99
Graduate in Economics, Senior Partner
T +49 761 888 51 23 20
F +49 761 888 51 23 99
